Chronic condition management had a leading Indian digital health platform known as BeatO has announced its entry into the Southeast Asian market with the launch of its operations in Singapore. To expand its presence in the ASEAN market and provide comprehensive digital diabetes care and self-management to Singapore the company has collaborated with Ascensia Diabetes Care.
Singapore has 10.5 percent diabetes, compared to the world average of 8.8 percent. This is because the expansion is in line with the company’s goals of maintaining markets with high levels of diabetes. The company plans to build new networks in international geography as it delves deeper into existing markets and forms a strong national network of partners.
Through its partnership with Ascensia, users can integrate with Beato’s application ecosystem with their Ascensia monitoring tools. BeatO will invest significantly in the development of businesses and improve products and introduce new technology in the Singapore market.
The BeatO app in Singapore has been customized to the lifestyle, usage, and culture of the local market.
As COVID-19 Impact Digital Health is rapidly adapting, the company commented that the increased frequency of blood sugar monitoring, interaction with diabetes educators, and consultation with doctors on the platform is the highest ever. By December, the company’s business revenue had tripled, compared to Covid’s.
BeatO has an active membership base of 150,000 people with chronic conditions and aims to reach half a million by the end of this financial year. BeatO is a full-fledged digital health platform for managing lifestyle-related chronic diseases – from diabetes which was founded in 2015.
At the start of Health-Tech Startup 2020, it has invested $ 4.1 million in Series A and received approximately US $ 7 million in funding from leading VCs and angel investors, including Leo Capital, Bloom Ventures, Orios Venture Partners, and Parkview Ventures.
The Smart Connected Chronic Care Management Ecosystem is powered by AI, which provides functional statistics for controlling diabetes and blood pressure, and offers users a full-fledged ecosystem to help them manage their chronic condition. Integrates low-cost IoT hardware with the BeatO application to support end-to-end management for users.
BeatO received ISO 13485: 2016 certification for Design & Development (Hardware, Software), Manufacturing, Sales, Marketing, and Post-Sales Support. Ensures that the entire product design and sales process has passed through rigorous testing and compliance.